Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?
Gabriel Herrero‐Beaumont, Raquel Largo
Topics & Concepts
MedicineOsteoarthritisGlucosamineCartilageInflammationDiseaseInternal medicineClinical trialSystemic inflammationPathologyChemistryOrganic chemistryAlternative medicineAnatomyOsteoarthritis Treatment and MechanismsImmune Response and InflammationChemokine receptors and signaling